Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Poor correlation between diameter and Breslow thickness of melanoma.
Salijuma E, Maskalane J, Lallas K, Papageorgiou C, Gkentsidi T, Manoli SM, Eftychidou P, Sakellaropoulou S, Nikolaidou C, Vakirlis E, Sotiriou E, Apalla Z, Lallas A. Salijuma E, et al. Among authors: eftychidou p. J Eur Acad Dermatol Venereol. 2024 Jan;38(1):e56-e58. doi: 10.1111/jdv.19431. Epub 2023 Aug 23. J Eur Acad Dermatol Venereol. 2024. PMID: 37595962 No abstract available.
Dermoscopic Clues of Histopathologically Aggressive Basal Cell Carcinoma Subtypes.
Camela E, Ilut Anca P, Lallas K, Papageorgiou C, Manoli SM, Gkentsidi T, Eftychidou P, Liopyris K, Sgouros D, Apalla Z, Lallas A. Camela E, et al. Among authors: eftychidou p. Medicina (Kaunas). 2023 Feb 13;59(2):349. doi: 10.3390/medicina59020349. Medicina (Kaunas). 2023. PMID: 36837550 Free PMC article.
Real-Life Data on the Management of Incompletely Excised Basal Cell Carcinoma.
Daviti M, Lallas K, Dimitriadis C, Moutsoudis A, Eleftheriadis V, Eftychidou P, Bakirtzi M, Stefanou E, Gkentsidi T, Papadimitriou I, Sotiriou E, Vakirlis E, Ioannides D, Lallas A. Daviti M, et al. Among authors: eftychidou p. Dermatology. 2023;239(3):429-435. doi: 10.1159/000529367. Epub 2023 Feb 2. Dermatology. 2023. PMID: 36731436 Free article.
Long-term drug survival of secukinumab in real life in the era of novel biologics: a 5-year, retrospective study, including difficult-to-treat areas.
Sotiriou E, Bakirtzi K, Vakirlis E, Papadimitriou I, Eftychidou P, Trifona M, Lallas A, Ioannides D. Sotiriou E, et al. Among authors: eftychidou p. J Eur Acad Dermatol Venereol. 2022 Aug;36(8):e626-e627. doi: 10.1111/jdv.18087. Epub 2022 Mar 26. J Eur Acad Dermatol Venereol. 2022. PMID: 35305054 No abstract available.
A head-to-head comparison of risankizumab and ixekizumab for genital psoriasis: a real-life, 24-week, prospective study.
Sotiriou E, Bakirtzi K, Papadimitriou I, Tsentemeidou A, Eftychidou P, Eleftheriadis V, Lallas A, Ioannides D, Vakirlis E. Sotiriou E, et al. Among authors: eftychidou p. J Eur Acad Dermatol Venereol. 2022 May;36(5):e359-e361. doi: 10.1111/jdv.17880. Epub 2021 Dec 31. J Eur Acad Dermatol Venereol. 2022. PMID: 34923693 No abstract available.